We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

90 hedge funds and large institutions have $46.9M invested in Avid Bioservices, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

291% more call options, than puts

Call options by funds: $266K | Put options by funds: $68K

106% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 16

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

15% more capital invested

Capital invested by funds: $40.9M → $46.9M (+$5.99M)

8% more funds holding

Funds holding: 8390 (+7)

Holders
90
Holders Change
+7
Holders Change %
+8.43%
% of All Funds
2.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
33
Reduced
16
Closed
7
Calls
$266K
Puts
$68K
Net Calls
+$198K
Net Calls Change
+$65K

CDMO Hedge Fund Activity: Q2 2015 in Review

90 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2015, worth a combined $46.9M — up 15% from $40.9M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CDMO positions and 7 closed out — a net gain of 7 holders — while 33 added to existing stakes and 16 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $2M. The largest seller was BlackRock Institutional Trust, cutting an estimated $208K.

  • 90 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2015, up from 83 in Q1 2015.
  • Funds reported $46.9M of Avid Bioservices, Inc. Common Stock stock for Q2 2015, up 15% quarter-over-quarter.
  • 14 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2015 and 7 closed out, a net change of +7 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2015 was Renaissance Technologies, an estimated $2M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q2 2015 was BlackRock Institutional Trust, an estimated $208K sold.

Based on aggregated 13F filings for Q2 2015.